Involvement of the dopaminergic and serotonergic systems in the antidepressant-like effect caused by 4-phenyl-1-(phenylselanylmethyl)-1,2,3- triazole

Life Sciences

Volumn 93, Issue 9-11, 2013, Pages 393-400

  Donato, Franciele ^a   De Gomes, Marcelo Gomes ^a   Goes, André Tiago Rossito ^a   Seus, Natália ^b   Alves, Diego ^b   Jesse, Cristiano Ricardo ^a   Savegnago, Lucielli ^b  

^a UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Antidepressant like; Heterocycles; Mice; Monoaminergic system; Selenium

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 PHENYL 1 (PHENYLSELANYLMETHYL) 1,2,3 TRIAZOLE; 5 HYDROXYINDOLEACETIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATININE; GLUTATHIONE TRANSFERASE; METHYSERGIDE; MONOAMINE; NORADRENALIN; PRAZOSIN; PROPRANOLOL; SEROTONIN; SULPIRIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; UREA; YOHIMBINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN CORTEX; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EXPOSURE; DRUG MECHANISM; ENZYME ACTIVITY; EXPLORATORY BEHAVIOR; EXPLORATORY RESEARCH; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMOBILIZATION; LIPID PEROXIDATION; LOCOMOTION; MALE; METABOLITE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; SEROTONINERGIC SYSTEM; TOXICITY; TURNOVER TIME; UREA BLOOD LEVEL;

ANTIDEPRESSANT-LIKE; HETEROCYCLES; MICE; MONOAMINERGIC SYSTEM; SELENIUM;

ANIMALS; ANTIDEPRESSIVE AGENTS; CATALASE; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE TRANSFERASE; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; ORGANOSELENIUM COMPOUNDS; SEROTONIN; TIME FACTORS; TOXICITY TESTS, ACUTE; TRIAZOLES;

MUS;

EID: 84883461398     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.07.024     Document Type: Article

References (52)

1. H. Aebi Catalase 'in vitro' Methods Enzymol 105 1984 121 127
2. D. Alves, J.S. Reis, C. Luchese, C.W. Nogueira, and G. Zeni Synthesis of 3-alkynylselenophene derivatives by a cooper-free Sonogashira crosscoupling reaction Eur J Org Chem 2 2008 377 382
3. B.T. Baune, R. Miller, J. McAfoose, M. Johnson, F. Quirk, and D. Mitchell The role of cognitive impairment in general functioning in major depression Psychiatry Res 176 2010 183 189
4. G.A. Behr, J.C.F. Moreira, and B.N. Frey Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder Oxid Med Cell Longev 609 2012 421 434
5. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
6. C.A. Brüning, A.C.G. Souza, B.M. Gai, G. Zeni, and C.W. Nogueira Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems Eur J Pharmacol 658 2011 145 149
7. B.W. Dunlop, and C.B. Nemeroff The role of dopamine in the pathophysiology of depression Arch Gen Psychiatry 64 2007 327 337
8. A.S. Elhwuegi Central monoamines and their role in major depression Prog Neuropsychopharmacol Biol Psychiatry 28 2004 435 451
9. G.L. Ellman Tissue sulfhydryl groups Arch Biochem Biophys 82 1959 70 77
10. A.C. Ferraz, J.A. Anselmo-Franci, S.R. Perosa, E.F. Castro-Neto, M.I. Bellissimo, and B.H. Oliveira Aminoacid and monoamine alterations in the cerebral cortex and hippocampus of mice submitted to ricinine-induced seizures Pharmacol Biochem Behav 72 2002 779 786
11. B.M. Gai, A.L. Stein, J.A. Roehrs, F.N. Bilheri, C.W. Nogueira, and G. Zeni Synthesis and antidepressant-like activity of selenophenes obtained via iron(III)-PhSeSePh-mediated cyclization of Z-selenoenynes Org Biomol Chem 10 2012 798 807
12. B.M. Gay, M. Prigol, A.L. Stein, and C.W. Nogueira Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: involvement of serotonergic system Neuropharmacology 59 2010 172 179
13. M.F.B. Gerzson, F.N.V. Victoria, C.S. Radatz, M.G. Gomes, S.B. Boeira, and R.G. Jacob In vitro antioxidant activity and in vivo antidepressant-like effect of α-(phenylselanyl) acetophenone in mice Pharmacol Biochem Behav 102 2012 21 29
14. W.H. Habig, M.J. Pabst, and W.B. Jakoby Glutathione S-transferases. The first enzymatic step in mercapturic acid formation J Biol Chem 249 1974 7130 7139
15. S. Haider, S. Khaliq, and D.J. Haleem Enhanced serotonergic neurotransmission in the hippocampus following tryptophan administration improves learning acquisition and memory consolidation in rats Pharmacol Rep 59 2007 53 57
16. W.C. Hawkes, and L. Hornbostel Effects of dietary selenium on mood in healthy men living in a metabolic research unit Biol Psychiatry 39 1996 121 128
17. 1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test Eur J Pharmacol 562 2007 72 76
18. M.Z. Jaffe Methods determining creatinine Physiol Chem 10 1986 39 40
19. C.R. Jesse, E.A. Wilhelm, C.F. Bortolatto, and C.W. Nogueira Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice Pharmacol Biochem Behav 95 2009 344 350
20. 3 receptors in the antidepressant-like effect caused by oral administration of bisselenide in mice Prog Neuropsychopharmacol Biol Psychiatry 34 2010 294 302
21. R.C. Kessler, and P.S. Wang Epidemiology of depression I.H. Gotlib, Ham- men C.L. Handbook of depression 2009 Guilford Press New York, NY 5 22
22. N. Kitanaka, J. Kitanaka, and M. Takemura Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor Neurochem Res 31 2006 829 837
23. V. Klimek, J.E. Schenck, H. Han, C.A. Stockmeier, and G.A. Ordway Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study Biol Psychiatry 52 2002 740 748
24. N. Kolla, Z. Wei, J.S. Richardson, and X.M. Li Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide J Psychiatry Neurosci 30 2005 196 201
25. K.R. Lobato, C.C. Cardoso, R.W. Binfaré, J. Budni, C.L.R. Wagner, and P.S. Brocardo α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression Behav Brain Res 209 2010 249 259
26. E.M. Mackay, and L.L. Mackay Methods determining urea J Clin Invest 4 1927 295 296
27. M. Maes, N. De Vos, R. Pioli, P. Demedts, A. Wauters, and H.A. Neels Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness J Affect Disord 58 2000 241 246
28. Q.Q. Mao, Y.F. Xian, S.P. Ip, and C.T. Che Involvement of serotonergic system in the antidepressant-like effect of piperine Prog Neuropsychopharmacol Biol Psychiatry 35 2011 1144 1147
29. F. Ng, M. Berk, O. Dean, and A.I. Bush Oxidative stress in psychiatric disorders: evidence base and therapeutic implications Int J Neuropsychopharmacol 11 2008 851 876
30. A. Nikiforuk, K. Gołembiowska, and P. Popik Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats Eur Neuropsychopharmacol 20 2010 37 48
31. M. Ninomiya, D.R. Garudb, and M. Koketsua Biologically significant selenium-containing heterocycles Coord Chem Rev 255 2011 2968 2990
32. O.F. O'Leary, A.J. Bechtholt, J.J. Crowley, T.E. Hill, M.E. Page, and I. Lucki Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test Psychopharmacology 192 2007 357 371
33. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358
34. C.E.S. Oliveira, B.M. Gai, B. Godoi, G. Zeni, and C.W. Nogueira The antidepressant-like action of a simple selenium-containing molecule, methyl phenyl selenide, in mice Eur J Pharmacol 690 2012 119 123
35. E.S. Paykel Depression: major problem for public health Epidemiol Psyhiatr 15 2006 4 10
36. T. Posser, M.P. Kaster, S.C. Baraúna, J.B. Rocha, A.L.S. Rodrigues, and R.B. Leal Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system Eur J Pharmacol 602 2009 85 91
37. M. Prigol, C.A. Brüning, G. Zeni, and C.W. Nogueira Protective effect of disubstituted diaryl diselenides on cerebral oxidative damage caused by sodium nitroprusside Biochem Eng J 45 2009 94 99
38. S. Reitman, and S. Frankel A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases Am J Clin Pathol 28 1957 56 63
39. G.Z. Réus, R.B. Stringari, B. Souza, F. Petronilho, F. Dal-Pizzol, and J.E. Hallak Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus Oxid Med Cell Longev 5 2010 325 331
40. A. Sarandol, E. Sarandol, S.S. Eker, S. Erdin, E. Vatansever, and S. Kirli Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems Hum Psychopharmacol Clin Exp 22 2007 67 73
41. N. Sartorius, T.C. Baghai, D.S. Baldwin, B. Barrett, U. Brand, and W. Fleischhacker Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence Int J Neuropsychoppharmacol 10 2007 1 207
42. T. Satoh, K. Ishige, and Y. Sagara Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps Neurosci Lett 371 2004 1 5
43. L. Savegnago, C.R. Jesse, L.G. Pinto, J.B. Rocha, C.W. Nogueira, and G. Zeni Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats Prog Neuropsychopharmacol Biol Psychiatry 31 2007 1261 1269
44. A.C. Scates, and P.M. Doraiswamy Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression Ann Pharmacother 34 2000 1302 1312
45. N. Seus, M.T. Saraiva, E.E. Alberto, L. Savegnago, and D. Alves Selenium compounds in Click Chemistry: copper catalyzed 1,3-dipolar cycloaddition of azidomethyl arylselenides and alkynes Tetrahedron 68 2012 419 425
46. L. Sher Possible role of selenium deficiency in the neurobiology of depression and suicidal behavior in patients with alcohol use disorders Int J Disabil Hum Dev 6 2007 227 230
47. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology 85 1985 367 370
48. H. Tsuboi, A. Tatsumi, K. Yamamoto, F. Kobayashi, K. Shimoi, and N. Kinae Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants J Affect Disord 91 2006 63 70
49. J.G. Villarinho, R. Fachinetto, F.V. Pinheiro, G.S. Sant'Anna, P. Machado, and P.A. Dombrowski Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice Prog Neuropsychopharmacol Biol Psychiatry 39 2012 31 39
50. R.N. Walsh, and R.A. Cummins The open-field test: a critical review Psychol Bull 83 1976 482 504
51. WHO Depression. World Health Organization [cited 2012 Apr 12] Available from http://www.who.int/mental-health/management/depression/definition/en/ 2011
52. A. Zafir, A. Ara, and N. Banu In vivo antioxidant status: a putative target of antidepressant action Prog Neuropsychopharmacol Biol Psychiatry 33 2009 220 228